Risk Stratification Model for Surveillance Interval Extension After Hot Endoscopic Mucosal Resection of Large Non-Pedunculated Colon Polyps

Background: Current guidelines recommend uniform 6-month surveillance after endoscopic mucosal resection (EMR) of large non-pedunculated colon polyps (LNPCPs). We aimed to develop and validate a risk stratification model to identify lesions at lower recurrence risk. Methods: Retrospective multicenter study utilizing prospectively maintained databases across 12 centers (2017-2024) evaluated LNPCPs ≥20 mm removed by hot EMR. Twenty variables underwent multivariate Cox regression with stepwise selection to identify recurrence predictors. Validation was performed in a separate single-center cohort. Results: The derivation cohort included 463 patients with 491 LNPCPs. Multivariate analysis identified four independent predictors: evidence of prior resection (HR 1.97, 95% CI 1.04-3.72, p=0.03), absence of margin ablation (HR 1.96, 95% CI 1.22-3.23, p=0.01), villous histology (HR 1.77, 95% CI 1.09-2.86, p=0.02), and ileocecal valve (ICV) involvement (HR 2.66, 95% CI 1.29-5.45, p=0.01). Validation in a separate cohort (169 patients, 187 polyps) demonstrated effective risk stratification performance (p<0.01). In the validation cohort, low-risk polyps (no prior resection, margin ablation performed, no villous histology, no ICV involvement) had recurrence risks of 2.2%, 5.4%, and 9.7% at 6, 12, and 18 months respectively, compared to 10.6%, 23.1% and 28.1% in high-risk polyps. No patients in either cohort developed high-grade dysplasia or invasive adenocarcinoma during follow-up. Conclusions: A simple four-factor model incorporating prior resection, margin ablation, villous histology, and ICV involvement stratifies recurrence detection risk after hot EMR. Absence of high-risk features may help identify patients at lower recurrence risk and provides a framework for future prospective studies evaluating risk-adapted surveillance strategies.

Authors

Institutions

Publication Details

Journal
Endoscopy
Published
2026-09-15
DOI
https://doi.org/10.1055/a-2955-8379
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Risk Stratification Model for Surveillance Interval Extension After Hot Endoscopic Mucosal Resection of Large Non-Pedunculated Colon Polyps

Douglas K. Pleskow, Michael B. Wallace, Saowanee Ngamruengphong, Daniel von Renteln et al.
Endoscopy
Gastric Cancer Management and Outcomes
article

Risk Stratification Model for Surveillance Interval Extension After Hot Endoscopic Mucosal Resection of Large Non-Pedunculated Colon Polyps

Douglas K. Pleskow, Michael B. Wallace, Saowanee Ngamruengphong, Daniel von Renteln, Thomas J. Wang, Matthew Moyer, Kanika Garg, Aleksandar Gavrić, John Guardiola, Ajaypal Singh, Neal Mehta, Dennis Yang, Christopher G. Chapman, Stuart R. Gordon, Joshua Melson, Agnieszka Maniak, John Levenick, Benjamin Schwartz, Heiko Pohl, Douglas K. Rex, Irving Waxman, Mouen A Khashab
article en

Abstract

Background: Current guidelines recommend uniform 6-month surveillance after endoscopic mucosal resection (EMR) of large non-pedunculated colon polyps (LNPCPs). We aimed to develop and validate a risk stratification model to identify lesions at lower recurrence risk. Methods: Retrospective multicenter study utilizing prospectively maintained databases across 12 centers (2017-2024) evaluated LNPCPs ≥20 mm removed by hot EMR. Twenty variables underwent multivariate Cox regression with stepwise selection to identify recurrence predictors. Validation was performed in a separate single-center cohort. Results: The derivation cohort included 463 patients with 491 LNPCPs. Multivariate analysis identified four independent predictors: evidence of prior resection (HR 1.97, 95% CI 1.04-3.72, p=0.03), absence of margin ablation (HR 1.96, 95% CI 1.22-3.23, p=0.01), villous histology (HR 1.77, 95% CI 1.09-2.86, p=0.02), and ileocecal valve (ICV) involvement (HR 2.66, 95% CI 1.29-5.45, p=0.01). Validation in a separate cohort (169 patients, 187 polyps) demonstrated effective risk stratification performance (p<0.01). In the validation cohort, low-risk polyps (no prior resection, margin ablation performed, no villous histology, no ICV involvement) had recurrence risks of 2.2%, 5.4%, and 9.7% at 6, 12, and 18 months respectively, compared to 10.6%, 23.1% and 28.1% in high-risk polyps. No patients in either cohort developed high-grade dysplasia or invasive adenocarcinoma during follow-up. Conclusions: A simple four-factor model incorporating prior resection, margin ablation, villous histology, and ICV involvement stratifies recurrence detection risk after hot EMR. Absence of high-risk features may help identify patients at lower recurrence risk and provides a framework for future prospective studies evaluating risk-adapted surveillance strategies.

Endoscopy
University of Southern California (US), Rush University Medical Center (US), Dartmouth–Hitchcock Medical Center (US), Beth Israel Deaconess Medical Center (US), Johns Hopkins University (US), AdventHealth Orlando (US), California Southern University (US), Ljubljana University Medical Centre (SI), Jacksonville College (US), White River Junction VA Medical Center (US), Banner - University Medical Center Tucson (US), Indiana University School of Medicine, Indiana University (US), Université de Montréal (CA), Penn State Milton S. Hershey Medical Center (US)
Good health and well-being
Openalex Percentile: Top 11%
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.